TVRD
NASDAQ · Pharmaceuticals
Tvardi Therapeutics Inc
$4.21
+0.00 (+0.00%)
Open$4.19
Previous Close$4.21
Day High$4.30
Day Low$4.08
52W High$43.65
52W Low$2.75
Volume—
Avg Volume44.9K
Market Cap38.70M
P/E Ratio—
EPS$-8.36
SectorPharmaceuticals
Analyst Ratings
Buy
14 analysts
Price Target
+804.3% upside
Current
$4.21
$4.21
Target
$38.07
$38.07
$23.38
$38.07 avg
$43.34
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 43.13M | 63.71M | 10.81M |
| Net Income | -428,301,862 | -569,382,091 | 2.98M |
| Profit Margin | -993.0% | -943.3% | 27.6% |
| EBITDA | -446,638,852 | -626,745,804 | 3.89M |
| Free Cash Flow | — | — | 2.37M |
| Rev Growth | -32.3% | -32.3% | +19.2% |
| Debt/Equity | — | — | 0.91 |
Pharmaceuticals Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| LLY | Eli Lilly and Co. | $948.45 | -2.72% | 36.1 | 913.24B |
| JNJ | Johnson & Johnson | $221.32 | -0.53% | 26.1 | 548.94B |
| MRK | Merck & Co. Inc. | $111.38 | -0.82% | 31.3 | 279.42B |
| PFE | Pfizer Inc. | $25.68 | -3.02% | 19.3 | 150.09B |
| BMY | Bristol-Myers Squibb Co | $56.16 | -0.16% | 17.0 | 120.08B |
| ZTS | Zoetis Inc | $82.83 | -5.13% | 21.5 | 57.37B |